Progress of Thai national vaccine “ChulaCov19” latest has requested to register for production in Thai factories for human trials in Phase 1, if the experimental results meet the goals set. The vaccine is expected to be registered by the end of 2022.
Today (7 May 65) the latest Thai nationality of the COVID-19 vaccine research study, Dr. Paisan Dankhum, Secretary-General of the Food and Drug Administration (FDA) revealed that the Chulakov- 19 (ChulaCov19) Vaccine Research Center mRNA type Faculty of Medicine Chulalongkorn University and Chulalongkorn Hospital, Thai Red Cross Society
has submitted documents for permission to register for vaccine production at a factory in Thailand with the Food and Drug Administration (FDA) for testing in people in Phase 1 from the original request for registration of production in factories abroad. When changing the manufacturing plant, additional permission is required to register a new manufacturing facility.
Dr. Paisan also stated that the researcher has continuously submitted supporting documents, and now the FDA does not have to request any additional information. The consideration is on how the research team will register to use it. It will be used as the 1st needle, the 2nd needle or the stimulation needle.
However, it must undergo phase 1 human trials and begin research in healthy individuals. However, if the test results of vaccines produced in Thailand meet the goals set The vaccine is expected to be registered by the end of 2022.
The Food and Drug Administration secretary-general also said that other vaccines The most recent registered is the Kovovac vaccine. Other private persons registered in Thailand previously The license is valid for 1 year and all licenses have been renewed.
Currently in the process of public relations for the responsible person to submit a request to adjust the registration of various types of coviral vaccines. It is a vaccine that is used in general situations. from the present that is still registered for use in emergencies Just as the United States has registered the Pfizer vaccine for use under normal circumstances. because now the information should be complete If it is registered as a vaccine that is used in general situations The manufacturer can negotiate to sell through a private company. But it’s up to whether there will be a sale or not. Because now most of them are sold to the government.
picture from www.chulavrc.org